Response to: Ruxolitinib withdrawal due to the COVID-19.

ABSTRACT:

SUBMITTER: Barbui T 

PROVIDER: S-EPMC7905976 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature